Novel lung cancer drug targets patients with ALK fusion gene

被引：0
|
作者：
不详
机构：
来源：
PHARMACOGENOMICS | 2011年 / 12卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1512 / 1512
页数：1
相关论文
共 50 条
  • [1] Novel lung cancer drug targets patients with GATA2 fusion gene
    不详
    [J]. FUTURE ONCOLOGY, 2011, 7 (11) : 1246 - 1246
  • [2] Novel ALK fusion partners in lung cancer
    Iyevleva, Aglaya G.
    Raskin, Grigory A.
    Tiurin, Vladislav I.
    Sokolenko, Anna P.
    Mitiushkina, Natalia V.
    Aleksakhina, Svetlana N.
    Garifullina, Aigul R.
    Strelkova, Tatiana N.
    Merkulov, Valery O.
    Ivantsov, Alexandr O.
    Kuligina, Ekatherina Sh.
    Pozharisski, Kazimir M.
    Togo, Alexandr V.
    Imyanitov, Evgeny N.
    [J]. CANCER LETTERS, 2015, 362 (01) : 116 - 121
  • [3] Novel ALK fusion assays show promise for lung cancer patients
    Bond, Theo
    Crisp, Alisa
    [J]. PHARMACOGENOMICS, 2013, 14 (03) : 231 - 232
  • [4] SMPD3-ALK: A novel ALK fusion gene in lung adenocarcinoma
    Liang, Yuepei
    Wang, Yang
    Wang, Wenjing
    Zhao, Juan
    Xu, Mian
    Zheng, Min
    [J]. CLINICAL GENETICS, 2021, 99 (03) : 488 - 489
  • [5] Targeting SLMAP-ALK-a novel gene fusion in lung adenocarcinoma
    Pagan, Carlos
    Barua, Subit
    Hsiao, Susan J.
    Mansukhani, Mahesh
    Saqi, Anjali
    Murty, Vundavalli
    Fernandes, Helen
    [J]. COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2019, 5 (03):
  • [6] TMED2-ALK, a Novel ALK Fusion Gene Identified in a Patient With Lung Adenocarcinoma
    Mao, Weijun
    Chen, Ruo
    Zhang, Junling
    Zheng, Mingfeng
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (03) : E37 - E39
  • [7] EFFECT OF ALK KINASE INHIBITOR (CRIZOTINIB)AGAINST ALK FUSION GENE POSITIVE LUNG CANCER PATIENTS AND THE PATTERN OF RECURRENCES
    Kimura, Hideki
    Iizasa, Toshihiko
    Matsui, Yukiko
    Yoshino, Mitsuru
    Shingyoji, Masato
    Itakura, Meiji
    Yokoi, Sana
    Itami, Makiko
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1170 - S1170
  • [8] PARD3-ALK: A novel ALK fusion gene identified in a patient with lung adenocarcinoma
    Yang, Liangwei
    Zhao, Weidi
    Zhu, Huangkai
    Li, Xi
    Zhao, Guofang
    [J]. LUNG CANCER, 2021, 154 : 219 - 220
  • [9] Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors
    Yang, Dafu
    Li, Dan
    Dai, Zhaoxia
    Ma, Yutong
    Ou, Qiuxiang
    Wu, Xue
    Cui, Saiqiong
    [J]. CANCER COMMUNICATIONS, 2021, 41 (02) : 183 - 186
  • [10] EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer
    Koivunen, Jussi P.
    Mermel, Craig
    Zejnullahu, Kreshnik
    Murphy, Carly
    Lifshits, Eugene
    Holmes, Alison J.
    Choi, Hwan Geun
    Kim, Jhingook
    Chiang, Derek
    Thomas, Roman
    Lee, Jinseon
    Richards, William G.
    Sugarbaker, David J.
    Ducko, Christopher
    Lindeman, Neal
    Marcoux, J. Paul
    Engelman, Jeffrey A.
    Gray, Nathanael S.
    Lee, Charles
    Meyerson, Matthew
    Janne, Pasi A.
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (13) : 4275 - 4283
12345